These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6298885)

  • 1. 6-Hydroxydopamine-induced blockade of hypothalamic obesity: critical role of brain dopamine-norepinephrine interaction.
    Coscina DV; Nobrega JN
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):369-72. PubMed ID: 6298885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered effects of desipramine on operant performance after 6-hydroxydopamine-induced depletion of brain dopamine or norepinephrine.
    O'Donnell JM; Seiden LS
    J Pharmacol Exp Ther; 1984 Jun; 229(3):629-35. PubMed ID: 6427446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-norepinephrine interactions in the development of hyperphagia and obesity following medial hypothalamic lesions.
    Nobrega JN; Coscina DV
    Pharmacol Biochem Behav; 1986 Aug; 25(2):401-9. PubMed ID: 3094039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic apomorphine on the development of denervation supersensitivity.
    Robin M; Forler C; Palfreyman MG
    Pharmacol Biochem Behav; 1985 Apr; 22(4):547-51. PubMed ID: 3921992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress-induced neurological impairments in an animal model of parkinsonism.
    Snyder AM; Stricker EM; Zigmond MJ
    Ann Neurol; 1985 Nov; 18(5):544-51. PubMed ID: 3935041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of hyperactivity in adult rats induced by neonatal intraventricular 6-hydroxydopamine following pargyline or desmethylimipramine treatment.
    Olds ME; Yuwiler A
    Psychopharmacology (Berl); 1985; 87(4):484-9. PubMed ID: 3936107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overeating after midbrain 6-hydroxydopamine: prevention by central injection of selective catecholamine reuptake blockers.
    Hernandez L; Hoebel BG
    Brain Res; 1982 Aug; 245(2):333-43. PubMed ID: 6812851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the monoamine oxidase inhibitors clorgyline and pargyline on the hyperphagia of obese mice.
    Feldman JM
    Behav Brain Res; 1988 Jul; 29(1-2):147-58. PubMed ID: 2840925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral 6-hydroxydopamine lesions of dopamine neurons produce bilateral self-stimulation deficits.
    Carey RJ
    Behav Brain Res; 1982 Oct; 6(2):101-14. PubMed ID: 6814462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological investigation on the role of dopamine in the rat locus coeruleus.
    Milon H; McRae-Degueurce A
    Neurosci Lett; 1982 Jun; 30(3):297-301. PubMed ID: 6810240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability among brain regions in the specificity of 6-hydroxydopamine (6-OHDA)-induced lesions.
    Commins DL; Shaughnessy RA; Axt KJ; Vosmer G; Seiden LS
    J Neural Transm; 1989; 77(2-3):197-210. PubMed ID: 2503586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of central catecholamine alterations on the hypothermic response to 6-hydroxydopamine in desipramine treated rats.
    Breese GR; Howard JL
    Br J Pharmacol; 1971 Nov; 43(3):671-4. PubMed ID: 5157728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic hyperphagia prevented by damage to brain dopamine-containing neurons.
    Rowland N; Marshall JF; Antelman SM; Edwards DJ
    Physiol Behav; 1979 Apr; 22(4):635-40. PubMed ID: 482403
    [No Abstract]   [Full Text] [Related]  

  • 15. [Morphological restructurings in the brain due to a decrease in the catecholamine level].
    Otellin VA; Kucherenko RP; Gilerovich EG; Usova IP; Fedosikhina LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):978-81. PubMed ID: 6089476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epinephrine in rat hypothalamus: antagonism by desipramine of 6-hydroxydopamine-induced depletion.
    Tessel RE; Kennedy LE; Burgess SK; Borchardt RT
    Brain Res; 1978 Sep; 153(3):615-7. PubMed ID: 698800
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of nomifensine and desipramine on the sequelae of intracerebrally-injected 6-OHDA and 5,6-DHT.
    Waddington JL
    Pharmacol Biochem Behav; 1980 Dec; 13(6):915-7. PubMed ID: 7193877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norepinephrine stimulates behavioral activation in rats following depletion of nucleus accumbens dopamine.
    Swerdlow NR; Koob GF
    Pharmacol Biochem Behav; 1989 Jul; 33(3):595-9. PubMed ID: 2511575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of nigrostriatal dopamine system in the inhibition of thyrotropin secretion in the rat.
    Männistö P; Mattila J; Kaakkola S
    Eur J Pharmacol; 1981 Dec; 76(4):403-9. PubMed ID: 6799305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hypothalamic noradrenaline depletion with 6-hydroxydopamine on the body temperature regulation of the rat.
    Lin MT; Shian LR; Leu SY
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):131-5. PubMed ID: 6425702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.